4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-036168
Chief Executive Officer sold 8,800 shares at an average $48.56 ($427,288)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-05 | Sale | −3,200 | $49.51 | $158,432 | 168,078 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-05 | Sale | −1,200 | $50.27 | $60,324 | 166,878 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-06 | Sale | −1,900 | $46.53 | $88,407 | 164,978 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-06 | Sale | −1,500 | $47.69 | $71,535 | 163,478 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-06 | Sale | −1,000 | $48.59 | $48,590 | 162,478 | I |
| Open-market sales · 8,800 sh · avg $48.56 · $427,288 | |||||||
Loading xslF345X03/doc4.xml…